Cellerys AG

Reinventing MS therapy. Cellerys was founded in 2015 as a spin-out from the University of Zurich.

General Information
Company Name
Cellerys AG
Founded Year
2015
Location (Offices)
Schlieren, Switzerland +1
Founders / Decision Makers
Number of Employees
15
Industries
-
Funding Stage
-
Social Media

Cellerys AG - Company Profile

Reinventing MS therapy. Cellerys was founded in 2015 as a spin-out from the University of Zurich, where it conducted a successful phase I clinical trial with the support of Wyss Zurich, a joint accelerator of the University of Zurich and ETH Zurich. The phase I trial showed excellent tolerability and safety and indicated the induction of several tolerance mechanisms.

Funding Rounds & Investors of Cellerys AG (0)

View All

There is no investment information

Latest News of Cellerys AG

View All

No recent news or press coverage available for Cellerys AG.

Similar Companies to Cellerys AG

View All
CUTISS AG - Similar company to Cellerys AG
CUTISS AG Personalized & bioengineered human skin tissue therapy for patients with severe burns and skin injuries
Tryp Therapeutics - Similar company to Cellerys AG
Tryp Therapeutics Tryp is leading the next wave of psychedelic drug development.
EraCal Therapeutics - Similar company to Cellerys AG
EraCal Therapeutics Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-vivo screening platform
VIUN (previously VU Engineering) - Similar company to Cellerys AG
VIUN (previously VU Engineering) AI Defect Catalog for Industry 4.0
MindBio Therapeutics - Similar company to Cellerys AG
MindBio Therapeutics Advancing mental health treatments. Multiple Phase 2B clinical trials underway. Publicly listed on CSE:MBIO FRA:WF6.